Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! Get more Watchlists, Portfolios, Custom Views and Chart Templates with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Qualigen Therapeutics Inc (QLGN)

Qualigen Therapeutics Inc (QLGN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Qualigen Therapeutics Inc 5857 OWENS AVENUE SUITE 300 CARLSBAD CA 92008 USA

www.qlgntx.com P: 760-452-8111

Sector:

Medical

INDUSTRY GROUPING:

Medical - Drugs

Description:

Qualigen Therapeutics Inc. is a biotechnology company. It is focused on developing products for the treatment and testing of cancer and infectious diseases. The company's product pipeline consist AS1411 and Gold Nanoparticle ALAN, RAS-F3 and STARS(TM) blood cleansing system, which are in clinical stage. Qualigen Therapeutics Inc., formerly known as Ritter Pharmaceuticals Inc., is based in CA, United States.

Key Statistics

Overview:

Market Capitalization, $K 5,442
Enterprise Value, $K 9,992
Shares Outstanding, K 1,695
Float, K 1,665
% Float 98.20%
Short Interest, K 236
Short Float 0.00%
Days to Cover 1.00
Short Volume Ratio 0.48
% of Insider Shareholders 1.80%
% of Institutional Shareholders 3.18%

Financials:

Annual Sales, $ 0 K
Annual Net Income, $ -6,260 K
Last Quarter Sales, $ 0 K
Last Quarter Net Income, $ -2,040 K
EBIT, $ -5,370 K
EBITDA, $ -5,140 K

Growth:

1-Year Return -11.81%
3-Year Return -96.53%
5-Year Return -99.82%
5-Year Revenue Growth 0.00%
5-Year Earnings Growth 99.87%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -4.68 on 11/14/25
Next Earnings Date 06/29/26
Earnings Per Share ttm -7.50
EPS Growth vs. Prev Qtr -368.00%
EPS Growth vs. Prev Year 0.43%
Annual Dividend & Yield (Paid) 0.00 (0.00%)
Annual Dividend & Yield (Fwd) 0.00 (0.00%)
Dividend Payout Ratio 0.00%
Most Recent Split 1-50 on 11/05/24

QLGN Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % 0.00%
Return-on-Assets % -52.57%
Profit Margin % 0.00%
Debt/Equity -0.08
Price/Sales N/A
Price/Cash Flow N/A
Price/Book 2.22
Book Value/Share -1.01
Interest Coverage -5.76
60-Month Beta 0.24
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar